Information  X 
Enter a valid email address

Virotec Intl Ld (VTI)

  Print      Mail a friend

Thursday 17 June, 2004

Virotec Intl Ld

Director Shareholding

Virotec International Ld
17 June 2004

                           VIROTEC INTERNATIONAL LTD
                               ABN 81 004 801 398
17 June 2004

                      Change of Director's Interest Notice

Following advice from Dr Michael Nissen of a change in his shareholding in
Virotec Internatioanl Ltd (ASX/ AIM: VTI), the following information is
provvided to the market.


Name of Director                          Dr Michael Nissen
Date of last notice                       5 December 2003

Direct or indirect interest  Indirect and direct

Nature of indirect interest  Andwenrod Services Pty Ltd (a company controlled by
                             Dr Nissen) 7,300,000 shares
                             Wengale Pty Ltd (a company controlled by Dr Nissen)
                             100,000 shares
                             Mrs P.Nissen (wife of Dr Nissen) and D.Levy as 
                             trustee for P.Nissen Superannuation Fund 50,000 
                             shares
                             Dr M Nissen 100,000 shares

Date of change               16 June 2004
No. of securities held       7,550,000 Ordinary shares
prior to change
Class                        Ordinary shares
Number acquired              Nil
Number disposed              400,000 ordinary shares
Value/Consideration          A$0.805 per share
No. of securities held       7,150,000 Ordinary shares
after change
                             (Andwenrod Services Pty Ltd 7,000,000 shares, 
                             P.Nissen Super Fund 50,000 shares, 
                             Dr M Nissen 100,000 shares)
Nature of change             Disposal on market (ASX)


                           VIROTEC INTERNATIONAL LTD
                               ABN 81 004 801 398
                                   PO Box 188
                       Sanctuary Cove QLD 4212 Australia
                                www.virotec.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange